An interventional study of Auricular Point Acupressure (APA) - Self Management (SM) and Education Control in Chronic Pain (Back / Neck), Chronic Pain Management and Chronic Knee Pain, sponsored by The University of Texas Health Science Center, Houston. Recruiting at 3 sites in United States. Open to participants aged 18 Years to 85 Years. Per ClinicalTrials.gov, last updated 2025-10-01.
Sponsored by The University of Texas Health Science Center, Houston · Not applicable, Interventional, and Treatment
The investigators will test an Auricular Point Acupressure Self-Management (APA-SM) program integrated into rural primary and specialty care and rural communities for chronic musculoskeletal pain (CMP). To maximize self-management of pain, the investigators developed a smartphone app which will allow the participants to learn to self-administer APA. The investigators will have 3 arms (APA-SM self-guided with remote training, APA-SM with in-person training, and Education Control) with 231 participants per arm (total=693 for 3 arms). The investigators will evaluate the clinical effectiveness of our 4-week APA-SM intervention compared to control in primary outcomes (pain intensity, pain interference, activity), secondary outcomes (HEAL Clinical Pain Core common data elements), and analgesic use up to 6 months follow-up.
The investigators integrated ecological momentary assessment into our app to measure real-world outcomes resulting in participants being able to self-monitor their progress, using this as an innovative behavior change strategy based on Bandura's self-efficacy, successfully initiating and maintaining behavior change. The primary endpoint will be immediate post-intervention with secondary endpoints at 1-month, 3-month, and 6-month follow-ups after the intervention. The investigators will also evaluate implementation outcomes and cost-effectiveness. Our long-term goal is to increase the access and scalability of evidence-based interventions while addressing pain care disparities for rural individuals with limited resources and/or endure long distances to specialty pain care. Study recruitment will be 3 1/2 to 4 years followed by data analysis.
2,930 studies on the registry are indexed under Chronic Pain; 701 are open to participants now.
This study's planned enrollment of 693 is above the median of 60 across 2,161 interventional studies indexed under Chronic Pain.
Browse Chronic Pain studies →The University of Texas Health Science Center, Houston is the lead sponsor of 880 studies on the registry; 209 are open to participants now.
Of its 170 completed or terminated interventional studies of FDA-regulated products, 140 (82%) have results posted.
Counted across the registry records on this site, refreshed daily.
Exclusion Criteria:
APA-SM self-guided with remote training
Behavioral: Auricular Point Acupressure (APA) - Self Management (SM)
APA-SM with in-person training
Behavioral: Auricular Point Acupressure (APA) - Self Management (SM)
Education Control
Behavioral: Education Control
APA is a noninvasive and needle-free pain management therapy based on the principles of acupuncture. The APA-SM intervention program is aimed to manage chronic musculoskeletal pain leveraging a mobile app containing APA videos and remote vs in-person guidance or coaching to practice APA based on APA study assignment.
Education Control group receive an app but the content will be specific to pain and self-management (no APA content) and they practice pain self-management skills (no APA practice).
Change in pain as assessed by the pain, enjoyment of life, general activity (PEG) survey
This is a three-item questionnaire and each is scored from 0 (no pain) to 10(worst pain) for a maximum score of 30. Higher score indicating worse outcome
Time frame: Baseline, post intervention (4 weeks after baseline), 1 month, 3 months, 6 months
Change in pain as assessed by the Pain Catastrophizing Scale (PCS6)
This is a six-item questionnaire and each is scored from 0 (not at all) to 4 (all the time) for a maximum score of 24. Higher score indicating greater pain catastrophizing.
Time frame: Baseline, post intervention (4 weeks after baseline)
Change in fear-avoidance beliefs as assessed by the Fear-Avoidance Beliefs Questionnaire (FABQ)
This is a 16-item questionnaire. Each item is scored from 0 (completely disagree) to 6 (completely agree) for a maximum score of 96. Higher score indicating greater fear-avoidance beliefs.
Time frame: Baseline, post intervention (4 weeks after baseline)
Change in depression as assessed by the Patient Health Questionnaire (PHQ2 )
This is a two-item questionnaire and each is scored from 0 (not at all) to 3(nearly every day) for a maximum score of 6. Higher score indicating greater depression.
Time frame: Baseline, post intervention (4 weeks after baseline)
Change in anxiety as assessed by the Generalized Anxiety Disorder (GAD2)
This is a two-item questionnaire and each is scored from 0 (not at all) to 3 (nearly every day) for a maximum score of 6. Higher score indicating more anxiety.
Time frame: Baseline, post intervention (4 weeks after baseline)
Change in severity of pain and its impact on functioning as assessed by the Brief Pain Inventory (BPI) Short From
This consist of six-item questionnaire regarding pain severity and nine-item questionnaire regarding pain interference. Higher score indicates greater pain severity and interference.
Time frame: Baseline, post intervention (4 weeks after baseline)
Change in physical function as assessed by the Patient-Reported Outcomes Measurement Information System (PROMIS) Physical Function short form 6b (SF6b)
This is a six-item questionnaire and each is scored from 1 (unable to do) to 5 (without any difficulty) for a maximum score of 30. Higher score indicates better physical function.
Time frame: Baseline, post intervention (4 weeks after baseline)
Change in disability as assessed by the Roland Morris Disability Questionnaire (RMDQ)
This is a 24-item questionnaire and each is scored 0 (no) or 1 (yes) for a maximum score of 24. Higher score indicates greater disability.
Time frame: Baseline, post intervention (4 weeks after baseline)
Change in sleep duration as assessed by the Patient-Reported Outcomes Measurement Information System (PROMIS) for Sleep 6a (+Sleep Duration)
This is a six-item questionnaire and each is scored from 1 (very good) to 5 (very poor) for a maximum score of 30. Higher scores indicate worse sleep disturbance. It also includes an additional single item (+Sleep Duration) assessing hours and minutes of sleep per night. Higher values indicates longer sleep duration.
Time frame: Baseline, post intervention (4 weeks after baseline)
Change in pain self-efficacy influenced by pain as assessed by the Pain Self-Efficacy Questionnaire 2 item Short Form (PSEQ2)
This is a two-item questionnaire and each is scored from 0 (not at all confident) to 6 (completely confident) for a maximum score of 12. Higher score indicating greater pain self-efficacy.
Time frame: Baseline, post intervention (4 weeks after baseline)
Change in substance use as assessed by the Tobacco, Alcohol, Prescription medication, and other Substance (TAPS1) Substance Use Screener
This is a five-item questionnaire and each is scored from 0 (daily or almost daily) to 4 (never) for a maximum score of 20. Higher score indicates lower substance use.
Time frame: Baseline, post intervention (4 weeks after baseline)
Change in quality of life as assessed by the World Health Organization Quality of Life 2 item (WHOQOL-2)
This is a two-item questionnaire and each is scored from 1 (very poor/dissatisfied) to 5 (very good/satisfied) for a maximum score of 10. Higher score indicating better quality of life.
Time frame: Baseline, post intervention(4 weeks after baseline)
Change in positive outlook as assessed by the Healing Encounters and Attitudes Lists (HEAL)
This is a six-item questionnaire and each is scored from 1 (not at all) to 5 (very much) for a maximum score of 30. Higher score indicates greater positive outlook.
Time frame: Baseline, post intervention(4 weeks after baseline)
Change in treatment expectancy as assessed by the Healing Encounters and Attitudes Lists (HEAL)
This is a six-item questionnaire and each is scored from 1 (not at all) to 5 (very much) for a maximum score of 30. Higher score indicates greater treatment expectancy.
Time frame: Baseline, post intervention(4 weeks after baseline)
Change in attitude towards complement alternative medicine (CAM) as assessed by the Healing Encounters and Attitudes Lists (HEAL)
This is a six-item questionnaire and each is scored from 1 (not at all) to 5 (very much) for a maximum score of 30. Higher score indicates more positive attitude toward CAM.
Time frame: Baseline, post intervention (4 weeks after baseline)
Change in analgesics and opioid use as assessed by the Ecological Momentary Assessment (EMA) diary
Daily self-reported analgesic and opioid use (type, dose, frequency) recorded via EMA diary
Time frame: Baseline, post intervention (4 weeks after baseline)
Plan to share: No — We have a Data Management and Sharing Plan and will comply with the policy set forth by NIH.
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
Contact study teamGet an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
The University of Texas Health Science Center, Houston